Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Impel Pharmaceuticals Inc (NQ: IMPL )

1.320 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,187
Open 1.310
Bid (Size) 1.250 (10)
Ask (Size) 1.340 (5)
Prev. Close 1.320
Today's Range 1.300 - 1.370
52wk Range 0.9275 - 10.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga

Performance

YTD
-66.15%
-66.15%
1 Month
-40.00%
-40.00%
3 Month
-8.33%
-8.33%
6 Month
-55.10%
-55.10%
1 Year
-81.30%
-81.30%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Recap: Impel Pharmaceuticals Q1 Earnings
Via Benzinga
Earnings Outlook For Impel Pharmaceuticals
Via Benzinga
Impel NeuroPharma Earnings Preview
Via Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For May 12, 2023
Via Benzinga
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting
From Impel Pharmaceuticals
Via GlobeNewswire
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 24, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
From Impel Pharmaceuticals
Via GlobeNewswire
Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
From Impel Pharmaceuticals
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.